Literature DB >> 29995979

Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014.

Jacky Shui Ho Chan1, Amelia Chien Wei Chao1, Vincent Chi Ho Cheung1, Sophia Sau Kuen Wong1, Whitney Tang1, Justin Che Yuen Wu1, Henry Lik Yuen Chan1, Francis Ka Leung Chan1, Joseph Jao Yiu Sung1, Siew Chien Ng1.   

Abstract

BACKGROUND AND AIM: Gastrointestinal (GI) diseases account for substantial morbidity, mortality, and health care utilization. This public hospital-based study assessed the incidence and time trend of hospitalization and mortality of major GI diseases over one decade.
METHODS: We conducted an observational study using population-wide database managed by the Hong Kong Hospital Authority with a principal diagnosis of GI diseases defined by International Classification of Disease, 9th Revision, Clinical Modification coding. We measured age-standardized incidence of hospitalization, emergency admissions, multiple admissions, and in-hospital mortality from 2005 to 2014 using Poisson regression.
RESULTS: The annual incidence of hospitalization for GI diseases increased from 4713 to 5241 per 100 000 discharges (incidence rate ratio [IRR] = 1.004; 95% confidence interval [CI]: 1.003-1.005). GI infections and cancers showed the highest rates of hospitalization in 2014. Hospitalization for GI cancers (IRR = 1.014; 95% CI: 1.013-1.016) and non-infectious enterocolitis (IRR = 1.058; 95% CI: 1.055-1.061) increased, whereas peptic ulcer disease has decreased. Hospitalization for Crohn's disease showed the most significant rise (126%). Annual incidence of hospitalization for Clostridium difficile infections increased by fivefold (IRR = 1.221; 95% CI: 1.178-1.266), while a 66% reduction was observed for peptic ulcer bleeding (IRR = 0.894; 95% CI: 0.889-0.899). GI cancers had the highest in-hospital mortality rate in 2014, especially colorectal cancer and gastric cancer.
CONCLUSIONS: This study showed an increased hospitalization burden of GI cancers and Crohn's disease, and a reduction in overall mortality for GI diseases. These data provide insight into epidemiological changes of GI diseases in the 21st century and implications for hospital burden and need of resource re-allocation.
© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Hong Kong; burden; epidemiology; gastrointestinal

Mesh:

Year:  2018        PMID: 29995979     DOI: 10.1111/jgh.14377

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases.

Authors:  Masoumeh Atefi; Mina Darand; Mohammad Hassan Entezari; Tannaz Jamialahmadi; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The effects of early enteral nutrition on the nutritional statuses, gastrointestinal functions, and inflammatory responses of gastrointestinal tumor patients.

Authors:  Rong Chen; Weijuan Yin; Hui Gao; Hongpeng Zhang; Yingqi Huang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Intelligent magnetic manipulation for gastrointestinal ultrasound.

Authors:  Joseph C Norton; Piotr R Slawinski; Holly S Lay; James W Martin; Benjamin F Cox; Gerard Cummins; Marc P Y Desmulliez; Richard E Clutton; Keith L Obstein; Sandy Cochran; Pietro Valdastri
Journal:  Sci Robot       Date:  2019-06-19

4.  Delta neutrophil index as a predictor of disease severity, surgical outcomes, and mortality rates in gastrointestinal diseases: Rationale for a meta-analysis of diagnostic test accuracy.

Authors:  Jae Ho Choi; Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.889

5.  Delta Neutrophil Index for the Prediction of Prognosis in Acute Gastrointestinal Diseases; Diagnostic Test Accuracy Meta-Analysis.

Authors:  Hae Min Jeong; Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  J Clin Med       Date:  2020-04-15       Impact factor: 4.241

6.  Differences between expert reported and patient reported burden of disease rankings.

Authors:  Damien S E Broekharst; Sjaak Bloem; Edward A G Groenland; W Fred van Raaij; Michel van Agthoven
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.